Myelofibrosis | Oncology Today with Dr Neil Love: Novel Agents and Strategies in Myelofibrosis (Companion Faculty Lecture)

Featuring a slide presentation and related discussion from Dr Ruben Mesa, including the following topics:

Efficacy and safety of FDA-approved JAK inhibitors for the management of myelofibrosis (MF) (0:00)

Emerging JAK inhibitors under Phase III evaluation for MF (6:59)

Current guidelines and strategies for managing MF (13:53)

Emerging data with novel agents and strategies for MF (17:31)

Splenic response and symptomology in patients with MF (25:36)

CME information and select publications

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.